Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Zellers CL"'
Autor:
Babic A; Dana-Farber Cancer Institute, Boston, Massachusetts. ababic1@partners.org., Rosenthal MH; Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts., Bamlet WR; Mayo Clinic Cancer Center, Rochester, Minnesota., Takahashi N; Mayo Clinic Cancer Center, Rochester, Minnesota., Sugimoto M; Mayo Clinic Cancer Center, Rochester, Minnesota., Danai LV; Department of Biochemistry and Molecular Biology, University of Massachusetts Amherst, Amherst, Massachusetts., Morales-Oyarvide V; Dana-Farber Cancer Institute, Boston, Massachusetts., Khalaf N; Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts., Dunne RF; Division of Hematology/Oncology, University of Rochester Medical Center, Rochester, New York., Brais LK; Dana-Farber Cancer Institute, Boston, Massachusetts., Welch MW; Dana-Farber Cancer Institute, Boston, Massachusetts., Zellers CL; Dana-Farber Cancer Institute, Boston, Massachusetts., Dennis C; Broad Institute of MIT and Harvard University, Cambridge, Massachusetts., Rifai N; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Prado CM; Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Canada., Caan B; Kaiser Permanente Division of Research, Oakland, California., Sundaresan TK; Kaiser Permanente San Francisco, San Francisco, California., Meyerhardt JA; Dana-Farber Cancer Institute, Boston, Massachusetts., Kulke MH; Dana-Farber Cancer Institute, Boston, Massachusetts.; Boston University and Boston Medical Center, Section of Hematology/Oncology, Boston, Massachusetts., Clish CB; Broad Institute of MIT and Harvard University, Cambridge, Massachusetts., Ng K; Dana-Farber Cancer Institute, Boston, Massachusetts., Vander Heiden MG; Dana-Farber Cancer Institute, Boston, Massachusetts.; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts., Petersen GM; Mayo Clinic Cancer Center, Rochester, Minnesota., Wolpin BM; Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2019 Dec; Vol. 28 (12), pp. 2062-2069. Date of Electronic Publication: 2019 Sep 18.
Autor:
Qian ZR; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Nowak JA; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Morales-Oyarvide V; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Dunne RF; Division of Hematology and Oncology, Department of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York., Kozak MM; Department of Radiation Oncology, Stanford Cancer Institute, Stanford, California., Welch MW; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Da Silva A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Li T; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Li W; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Masuda A; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Yang J; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Shi Y; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gu M; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Masugi Y; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Bui J; Department of Radiation Oncology, Stanford Cancer Institute, Stanford, California., Zellers CL; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Yuan C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts., Babic A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Khalaf N; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts., Aguirre A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Miksad RA; Department of Hematology and Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts., Bullock AJ; Department of Hematology and Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts., Chang DT; Department of Radiation Oncology, Stanford Cancer Institute, Stanford, California., Tseng JF; Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts., Clancy TE; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Linehan DC; Department of Surgery, University of Rochester Medical Center, Rochester, New York., Findeis-Hosey JJ; Department of Pathology, University of Rochester Medical Center, Rochester, New York., Doyle LA; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Thorner AR; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts., Ducar M; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts., Wollison B; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts., Laing A; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts., Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts., Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts., Fuchs CS; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Ogino S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.; Division of Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Hornick JL; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Hezel AF; Division of Hematology and Oncology, Department of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York., Koong AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
Publikováno v:
JAMA oncology [JAMA Oncol] 2018 Mar 08; Vol. 4 (3), pp. e173420. Date of Electronic Publication: 2018 Mar 08.
Autor:
Morales-Oyarvide V; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA., Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA., Dunne RF; Department of Medicine, Division of Hematology and Oncology, Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA., Kozak MM; Department of Radiation Oncology, Stanford Cancer Institute, 269 Campus Drive West, Stanford, CA 94305-5152, USA., Bui JL; Department of Radiation Oncology, Stanford Cancer Institute, 269 Campus Drive West, Stanford, CA 94305-5152, USA., Yuan C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA.; Department of Epidemiology, Harvard TH Chan School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA., Qian ZR; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA., Babic A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA., Da Silva A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA., Nowak JA; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA., Khalaf N; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA., Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA., Welch MW; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA., Zellers CL; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA., Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA., Chang DT; Department of Radiation Oncology, Stanford Cancer Institute, 269 Campus Drive West, Stanford, CA 94305-5152, USA., Miksad RA; Department of Hematology and Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA., Bullock AJ; Department of Hematology and Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA., Tseng JF; Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA., Swanson RS; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA., Clancy TE; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA., Linehan DC; Department of Surgery, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA., Findeis-Hosey JJ; Department of Pathology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA., Doyle LA; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA., Hornick JL; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA., Ogino S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA.; Department of Epidemiology, Harvard TH Chan School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA., Fuchs CS; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA., Hezel AF; Department of Medicine, Division of Hematology and Oncology, Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA., Koong AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1840 Old Spanish Trail, Houston, TX 77054, USA., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA.
Publikováno v:
British journal of cancer [Br J Cancer] 2017 Dec 05; Vol. 117 (12), pp. 1874-1882. Date of Electronic Publication: 2017 Oct 05.